All The Claims

1. Apparatus comprising:
a) a touch screen having a top surface, wherein a vertical height direction is perpendicular to the top surface of the touch screen, and wherein lateral directions are parallel to the top surface of the touch screen;
b) an overlay structure disposed on the top surface of the touch screen, wherein the overlay structure is capable of being actuated between a first state and a second state by a mechanical force applied in one or more lateral directions to one or more lateral edges of the overlay structure; and
c) an actuator capable of actuating the overlay structure to be in the first state or in the second state;
wherein the first state of the overlay structure is a configuration wherein the overlay structure has a substantially uniform top surface;
wherein the second state of the overlay structure is a configuration wherein the top surface of the overlay structure has increased z-height, relative to other parts of the overlay structure, at one or more predetermined lateral positions; and
wherein the touch screen is responsive to touch provided to the overlay structure at the one or more predetermined lateral positions when the overlay structure is in the second state.
2. The apparatus of claim 1, wherein the overlay structure comprises a first elastomer having one or more inclusions that are more mechanically rigid than the first elastomer, and wherein the overlay structure is actuated between the first and second states by providing lateral tension to the overlay structure with the actuator.
3. The apparatus of claim 2, wherein the one or more inclusions comprise a film embedded into the overlay structure such that the film has a substantially zig-zag configuration in the first state, and has a substantially planar configuration in the second state.
4. The apparatus of claim 2, wherein the one or more inclusions comprise localized bodies of a second elastomer disposed at the predetermined lateral positions.
5. The apparatus of claim 1, wherein the overlay structure comprises an elastic top layer and a bottom layer disposed on the touch screen, wherein the top and bottom layers mate at an interface having a saw tooth configuration, and wherein the overlay structure is actuated between the first and second states by laterally moving the top layer with respect to the bottom layer.
6. The apparatus of claim 5, further comprising one or more lubrication layers disposed at the interface.
7. The apparatus of claim 1, wherein the overlay structure comprises an elastic top layer and a bottom layer disposed on the touch screen, and wherein the overlay structure is actuated between the first and second states by altering a mechanical configuration of the bottom layer.
8. The apparatus of claim 7, wherein the bottom layer comprises one or more straps capable of deforming the bottom layer to provide tent-like shapes when lateral tension is applied to the straps.
9. The apparatus of claim 7, wherein the bottom layer is affixed to the touch screen at one or more localized attachment locations, whereby tent-like shapes can form in the bottom layer when the bottom layer is moved in a lateral direction.
10. The apparatus of claim 7, wherein the elastic top layer has the same lateral position in the first and second states of the overlay structure.
11. The apparatus of claim 1, wherein the overlay structure is substantially transparent to visible light.
12. The apparatus of claim 11, wherein the overlay structure includes two or more transparent materials having substantially matched indices of refraction.
13. The apparatus of claim 1, wherein the touch screen is capable of providing a visual display that is visible through the overlay structure.
14. The apparatus of claim 1, wherein the actuator has negligible power dissipation when the overlay structure is held in the first state or is held in the second state.
15. The apparatus of claim 1, wherein the actuator comprises an actuator selected from the group consisting of: magnetic solenoid latch, micro-relay, and bimetals.
16. The apparatus of claim 1, wherein the touch screen senses touch via electrical capacitance.
17. Apparatus capable of being disposed on a touch screen, the apparatus comprising:
a) an overlay structure configured to be disposed on a top surface of the touch screen, wherein a vertical height direction is perpendicular to a top surface of the touch screen, and wherein lateral directions are parallel to the top surface of the touch screen, wherein the overlay structure is capable of being actuated between a first state and a second state by a mechanical force applied in one or more lateral directions to one or more lateral edges of the overlay structure; and
b) an actuator capable of actuating the overlay structure to be in the first state or in the second state;
wherein the first state of the overlay structure is a configuration wherein the overlay structure has a substantially uniform top surface;
wherein the second state of the overlay structure is a configuration wherein the top surface of the overlay structure has increased z-height, relative to other parts of the overlay structure, at one or more predetermined lateral positions; and
wherein the touch screen is responsive to touch provided to the overlay structure at the one or more predetermined lateral positions when the overlay structure is in the second state.
The claims below are in addition to those above.
All refrences to claims which appear below refer to the numbering after this setence.

1. A rubber composition for a tire comprising:
(A) 100 parts by weight of a sulfur-vulcanizable diene-based rubber,
(B) 0.2 to 0.6 part by weight of 4,4\u2032-oxybis(benzenesulfonylazide),
(C) a vulcanization compounding agent and
(D) carbon black andor silica as a filler
wherein the ingredients (A), (B) and (D) are mixed at the time of a first mixing stage before the compounding of the ingredient (C).
2. A rubber composition as claimed in claim 1, wherein the diene based rubber is selected from the group consisting of natural rubber, butadiene rubbers and styrene-butadiene compolymer rubbers.
3. A pneumatic tire using a rubber composition according to claim 1.
4. A pneumatic tire using a rubber composition according to claim 2.

1. A compound, or a pharmaceutically acceptable salt thereof, selected from the up consisting of the compounds set forth in the following table:
943

944

945

946

947

948

949

950

951

952

953

954

955

956

957

958

959

960

961

962

963

964

965

966

967

968

969

970

971

972

973

974

975

976

977

978

979

980

981

982

983

984

985

986

987

988

989

990

991

992

993

994

995

996

997

998

999

1000

1001

1002

1003

1004

1005

1006
2. A pharmaceutical formulation comprising as an active ingredient a therapeutically effective amount of a compound according to claim 1 in association with one or more pharmaceutically acceptable diluents, excipients andor inert carriers.
3. The pharmaceutical formulation according to claim 2, for use in the prevention andor treatment of mGluR5 receptor-mediated disorders.
4. A compound according to claim 1 for use in therapy.
5. The compound according to claim 1, for use in prevention andor treatment of mGluR5 receptor-mediated disorders.
6. The compound according to claim 5, wherein the disorder is a neurological disorder.
7. The compound according to claim 5, wherein the disorder is a psychiatric disorder.
8. The compound according to claim 5, wherein the disorder is selected from chronic and acute pain disorders.
9. The compound according to claim 5, wherein the disorder is a gastrointestinal disorder.
10. The compound according to claim 5, wherein the disorder is selected from the group consisting of Alzheimer’s disease, senile dementia, AIDS-induced dementia, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington’s Chorea, migraine, epilepsy, schizophrenia, depression, anxiety, acute anxiety, obsessive compulsive disorder, opthalmological disorders, diabetic retinopathies, glaucoma, auditory neuropathic disorders, chemotherapy induced neuropathies, post-herpetic neuralgia and trigeminal neuralgia, tolerance, dependency, addiction and craving disorders, neurodevelopmental disorders, autism, mental retardation, schizophrenia, Down’s Syndrome, pain related to migraine, inflammatory pain, neuropathic pain disorders, arthritis and rheumatitiod diseases, low back pain, post-operative pain, pain associated with angina, renal and billiary colic, menstruation, migraine gout, stroke, head trauma, anoxic and ischemic injuries, hypoglycemia, cardiovascular diseases, GERD, and epilepsy.
11. The use of a compound according to claim 1 in the manufacture of a medicament for the use in the prevention andor treatment of mGluR5 receptor-mediated disorders.
12. A method of prevention andor treatment of mGluR5 receptor-mediated disorders, comprising administering to a mammal in need of such prevention andor treatment a therapeutically effective amount of a compound according to claim 1.
13. The method according to claim 12, wherein the disorder is a neurological disorder.
14. The method according to claim 12, wherein the disorder is a psychiatric disorder.
15. The method according to claim 12, wherein the disorder is selected from chronic and acute pain disorders.
16. The method according to claim 12, wherein the disorder is a gastrointestinal disorder.
17. The method according to claim 12, wherein the disorder is selected from the group consisting of Alzheimer’s disease, senile dementia, AIDS-induced dementia, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington’s Chorea, migraine, epilepsy, schizophrenia, depression, anxiety, acute anxiety, obsessive compulsive disorder, opthalmological disorders, diabetic retinopathies, glaucoma, auditory neuropathic disorders, chemotherapy induced neuropathies, post-herpetic neuralgia and trigeminal neuralgia, tolerance, dependency, addiction and craving disorders, neurodevelopmental disorders, autism, mental retardation, schizophrenia, Down’s Syndrome, pain related to migraine, inflammatory pain, neuropathic pain disorders, arthritis and rheumatitiod diseases, low back pain, post-operative pain, pain associated with angina, renal and billiary colic, menstruation, migraine gout, stroke, head trauma, anoxic and ischemic injuries, hypoglycemia, cardiovascular diseases and epilepsy.
18. A method for inhibiting the activation of mGluR5 receptors, comprising treating a cell containing said receptor with an effective amount of a compound according to claim 1.

The claims below are in addition to those above.
All refrences to claims which appear below refer to the numbering after this setence.

What is claimed is:

1. An attachment air inlet configuration for a turbine blade comprising:
an attachment having a root portion with a center plane;
a plurality of inlets in said root portion of said attachment communicating with at least two flow passageways in said blade;
each of said inlets having a non-circular shape with a major axis; and
said major axis being substantially normal to said root portion center plane.
2. An attachment air inlet configuration according to claim 1, wherein said attachment has a firtree configuration with a minimum neck section and wherein said blade has a plurality of ribs extending along an axis substantially perpendicular to said root portion center plane to define a plurality of inlet channels communicating with said inlets.
3. An attachment air inlet configuration according to claim 2, wherein each of said inlet channels has an elliptical shape.
4. An attachment air inlet configuration according to claim 2, further comprising each of said ribs having a first thickness in a region above the minimum neck section and a variable thickness greater than said first thickness in a region below said minimum neck section.
5. An attachment air inlet configuration according to claim 4, wherein said plurality of ribs include a central rib which forms two flow passageways in said blade and each of said inlet channels communicates with one of said flow passageways.
6. An attachment air inlet configuration according to claim 4, wherein each of said ribs occupies a first area in the region above said minimum neck section and a second area larger than said first area in the region below said minimum neck section.
7. An attachment air inlet configuration according to claim 2, wherein each of said inlet channels has a first flow area at said minimum neck section and a variable flow area larger than said first flow area beneath said minimum neck section.
8. An attachment air inlet configuration according to claim 6, further comprising each of said inlet channels having a curved transition section extending between a respective one of said inlets and said minimum neck section.
9. An attachment air inlet configuration according to claim 1, wherein said blade is a single crystal turbine blade.
10. An attachment air inlet configuration according to claim 9, wherein said single crystal turbine blade has a random secondary crystal orientation.
11. An attachment air inlet configuration according to claim 2, wherein said attachment has a rounded lower surface.